- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| STRYKER CORPORATION CDR Aktie jetzt für 0€ handeln | |||||
| 02.07. | Night Watch Investment Management adds Stryker, Adyen; trims WDC, SIMO among Q2 moves | 12 | Seeking Alpha | ||
| 30.06. | If You Invested $1000 In Stryker Stock 20 Years Ago, You Would Have This Much Today | 12 | Benzinga.com | ||
| 28.06. | Stryker Corporation (SYK) launches TPX HD Power Tool | 26 | Insider Monkey | ||
| 26.06. | STRYKER CORP - 8-K, Current Report | 19 | SEC Filings | ||
| 26.06. | First European case completed with Stryker Mako Shoulder in Ireland | 18 | MassDevice | ||
| 26.06. | Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss | 20 | Insider Monkey | ||
| 24.06. | Stryker, pro golfer Shane Lowry partner on joint replacement awareness | 9 | MassDevice | ||
| 24.06. | Stryker Taps Irish Golf Star Shane Lowry To Reach Caregivers | 4 | Forbes | ||
| 20.06. | Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run | 25 | Insider Monkey | ||
| 12.06. | Here's Why You Should Hold Stryker Stock in Your Portfolio for Now | 27 | Zacks | ||
| 05.06. | Leerink cuts Stryker stock price target to $407 on model update | 34 | Investing.com | ||
| 05.06. | The Stryker Attack Shows Growing Gaps in Mobile Device Security | 19 | The Fast Mode | ||
| 02.06. | Stryker launches new small bone power tool for orthopedic procedures | 8 | MassDevice | ||
| 01.06. | Is Stryker Stock Underperforming the S&P 500? | 11 | Barchart.com | ||
| 29.05. | Hedge Fund and Insider Trading News: Ken Griffin, Michael Burry, Bill Ackman, Warren Buffett, Voss Capital, Cinctive Capital Management, Stryker Corp (SYK), Twilio Inc (TWLO), and More | 36 | Insider Monkey | ||
| 29.05. | Director Of Stryker Sold $96.79M In Stock | 27 | Benzinga.com | ||
| 28.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 28.05.2026 | 471 | Xetra Newsboard | The following instruments on XETRA do have their first trading 28.05.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 28.05.2026
Aktien
1 CZ0009008819 Karo Leather a.s.
2... ► Artikel lesen | |
| 26.05. | Stryker bringt das Pangea-Plattensystem auf den Markt und schließt den ersten Eingriff in Europa ab | 681 | Business Wire | Stryker (NYSE:SYK), ein weltweit führendes Unternehmen im Bereich Medizintechnik, gab heute die Markteinführung seines Pangea-Plattensystems in Europa bekannt, einer Plattensystem-Plattform zur Behandlung... ► Artikel lesen | |
| 26.05. | Stryker launches Pangea plating system in Europe, reports first cases | 10 | MassDevice | ||
| 26.05. | Stryker Launches Pangea Plating System and Completes First Case in Europe | 540 | Business Wire | Stryker (NYSE:SYK), a global leader in medical technologies, announced today the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.... ► Artikel lesen |
1 2 3 4 5 Weiter >>
182 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 36,670 | +10,62 % | Dividendenbekanntmachungen (07.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABC ARBITRAGE SA FR0004040608 - 0,04 EUR ACCIONA SA ES0125220311 - 5,7486 EUR AMICA SA PLAMICA00010 2,5 PLN 0,5829 EUR ANY BIZTONSAGI... ► Artikel lesen | |
| VIRAX BIOLABS GROUP | 9,300 | +192,45 % | Morning Market Movers: Virax Biolabs, Aimei Health Technology, Sadot Group, Ionis Pharmaceuticals See Big Swings | BEIJING (dpa-AFX) - At 8:35 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| COGENT BIOSCIENCES | 40,820 | +2,13 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) | Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 133,40 | +0,11 % | AbbVie setzt mit Apogee-Übernahme neuen Akzent im Wettlauf um Blockbuster-Biologika | AbbVie stärkt mit der geplanten Übernahme von Apogee Therapeutics seine Position im Markt für Immunologie-Biologika und vertieft damit eine ohnehin schon dominante Wettbewerbsstellung. Der Deal zielt... ► Artikel lesen | |
| ABSCI | 11,355 | +2,30 % | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 62,28 | -8,05 % | Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101 | ||
| BEAM THERAPEUTICS | 36,120 | -2,06 % | BofA bestätigt Kaufempfehlung für Beam Therapeutics nach Schiedsspruch | ||
| VERA THERAPEUTICS | 42,180 | -0,59 % | Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner | BRISBANE, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced a planned transition of the Chief Regulatory Officer... ► Artikel lesen | |
| ERASCA | 19,510 | +3,39 % | Erasca, Inc.: Erasca Reports First Quarter 2026 Business Updates and Financial Results | Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 47,140 | +1,81 % | Oppenheimer initiates Edgewise Therapeutics stock with outperform rating | ||
| RECURSION PHARMACEUTICALS | 3,795 | +2,02 % | Recursion Pharmaceuticals: Recursion Reports First Quarter Financial Results and Provides Business Update | Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and predictable... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 28,670 | +0,60 % | Arcutis Biotherapeutics, Inc.: FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months | FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-label... ► Artikel lesen | |
| ALUMIS | 30,240 | +1,68 % | Alumis Aktie erreicht Rekordhoch bei 30,67 USD | ||
| RELAY THERAPEUTICS | 20,190 | +2,85 % | JPMorgan stuft Relay Therapeutics zum Start mit "Overweight" ein | ||
| CG ONCOLOGY | 73,24 | +4,92 % | CG Oncology Inc.: CG Oncology Reports Positive First Results from CORE-008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients | - High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the ITT population and Efficacy Evaluable population, respectively - High-Grade - EFS in the overall intention-to-treat... ► Artikel lesen |
STRYKER CORPORATION CDR gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 13,300 Euro und damit -0,75 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STRYKER CORPORATION CDR finden Sie auf Wallstreet Online.